Schedule 13G ownership disclosure

HOMOLOGY MEDICINES INC

Security class unavailable · CUSIP: 438083107

Event date: 2018-03-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,979,226
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-005517
Form type
SC 13G
Filer
Q32 Bio Inc.
CIK
CIK 1661998
Filed
Feb 04, 2019
Reporting period
Mar 27, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub